• ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
  • Benign prostatic hypertrophy
  • Adrenogenital disorder
  • Butorphanol, Urine
  • Albumin Creatinine Ratio
  • Bilirubin, Direct, Serum
  • Coagulation Factor VIII Activity Assay, Plasma
  • 5-Hydroxyindoleacetic Acid (5-HIAA), 24 Hour, Urine
  • Parainfluenza Virus (Types 1, 2, 3) Antibodies
  • Levetiracetam, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
Medical Test

Specimen Collection
Access to OncoExTra (Oncomap™ ExTra) for Metastatic Cancer is restricted.